Search Results - "Norris, Virginia"

Refine Results
  1. 1
  2. 2

    Stigma, Help-Seeking Attitudes, and Use of Psychotherapy in Veterans With Diagnoses of Posttraumatic Stress Disorder by Rosen, Craig S, Greenbaum, Mark A, Fitt, Julie E, Laffaye, Charlene, Norris, Virginia A, Kimerling, Rachel

    Published in The journal of nervous and mental disease (01-11-2011)
    “…Survey and medical record data from 482 Veterans Affairs (VA) patients who recently received diagnoses of posttraumatic stress disorder (PTSD) were examined to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Patient Perspectives on Breast Cancer Treatment Plan and Summary Documents in Community Oncology Care: A Pilot Program by BLINDER, Victoria S, NORRIS, Virginia W, PEACOCK, Nancy W, GRIGGS, Jennifer J, HARRINGTON, David P, MOORE, Anne, THERIAULT, Richard L, PARTRIDGE, Ann H

    Published in Cancer (2013)
    “…Although the routine use of treatment plans and summaries (TPSs) has been recommended to improve the quality of cancer care, limited data exist about their…”
    Get full text
    Journal Article
  5. 5

    The Changing Age of Individuals Seeking Presymptomatic Genetic Testing for Huntington Disease by Holman, Melissa A., Quillin, John, York, Timothy P., Testa, Claudia M., Rosen, Ami R., Norris, Virginia W.

    Published in Journal of genetic counseling (01-09-2018)
    “…Huntington disease (HD) is a progressive neurodegenerative disorder. Presymptomatic genetic testing allows at-risk individuals to clarify their risk status…”
    Get full text
    Journal Article
  6. 6

    Etiology of unilateral hearing loss in a national hereditary deafness repository by Dodson, Kelley M., MD, Georgolios, Alexandros, MD, Barr, Noelle, BS, Nguyen, Bich, MD, Sismanis, Aristides, MD, Arnos, Kathleen S., PhD, Norris, Virginia W., MS, Chapman, Derek, PhD, Nance, Walter E., MD PhD, Pandya, Arti, MD

    Published in American journal of otolaryngology (01-09-2012)
    “…Abstract Purpose The aim of this study was to characterize the genetic, audiologic, and epidemiologic characteristics of unilateral hearing loss (HL) in a…”
    Get full text
    Journal Article
  7. 7

    Does Universal Newborn Hearing Screening Identify All Children with GJB2 (Connexin 26) Deafness? Penetrance of GJB2 Deafness by Norris, Virginia W, Arnos, Kathleen S, Hanks, Wendy D, Xia, Xia, Nance, Walter E, Pandya, Arti

    Published in Ear and hearing (01-12-2006)
    “…OBJECTIVE:Deafness is the most common neurosensory defect at birth, and GJB2 (connexin 26) mutations are the most frequent genetic cause of hearing loss in…”
    Get full text
    Journal Article
  8. 8

    Implementing a breast cancer registry and treatment plan/summary program in clinical practice: A pilot program by Partridge, Ann H., Norris, Virginia W., Blinder, Victoria S., Cutter, Bruce A., Halpern, Michael T., Malin, Jennifer, Neuss, Michael N., Wolff, Antonio C.

    Published in Cancer (01-01-2013)
    “…BACKGROUND: There is a need to better measure and improve the quality of oncology care and improve communication with patients and other providers. The…”
    Get full text
    Journal Article
  9. 9

    A Comparative Analysis of the Genetic Epidemiology of Deafness in the United States in Two Sets of Pedigrees Collected More than a Century Apart by Arnos, Kathleen S., Welch, Katherine O., Tekin, Mustafa, Norris, Virginia W., Blanton, Susan H., Pandya, Arti, Nance, Walter E.

    Published in American journal of human genetics (01-08-2008)
    “…In 1898, E.A. Fay published an analysis of nearly 5000 marriages among deaf individuals in America collected during the 19th century. Each pedigree included…”
    Get full text
    Journal Article
  10. 10

    Vestibular dysfunction in DFNB1 deafness by Dodson, Kelley M., Blanton, Susan H, Welch, Katherine O, Norris, Virginia W, Nuzzo, Regina L, Wegelin, Jacob A., Marin, Ruth S, Nance, Walter E, Pandya, Arti, Arnos, Kathleen S

    “…Mutations of GJB2 and GJB6 (connexin‐26 and 30) at the DFNB1 locus are the most common cause of autosomal recessive, nonsyndromic deafness. Despite their…”
    Get full text
    Journal Article
  11. 11

    Impact of genetic advances and testing for hearing loss: Results from a national consumer survey by Withrow, Kara A., Tracy, Kelly A., Burton, Sarah K., Norris, Virginia W., Maes, Hermine H., Arnos, Kathleen S., Pandya, Arti

    “…Hearing loss is a common neuro‐sensory deficit; nearly 50% of children with hearing loss have a genetic etiology. With the discovery of 40 genes and more than…”
    Get full text
    Journal Article
  12. 12

    Fitness Among Individuals with Early Childhood Deafness: Studies in Alumni Families from Gallaudet University by Blanton, Susan H., Nance, Walter E., Norris, Virginia W., Welch, Katherine O., Burt, Amber, Pandya, Arti, Arnos, Kathleen S.

    Published in Annals of human genetics (01-01-2010)
    “…Summary The genetic fitness of an individual is influenced by their phenotype, genotype and family and social structure of the population in which they live…”
    Get full text
    Journal Article
  13. 13

    Provision of Genetic Services for Hearing Loss: Results from a National Survey and Comparison to Insights Obtained from Previous Focus Group Discussions by Withrow, Kara Anne, Tracy, Kelly A., Burton, Sarah K., Norris, Virginia W., Maes, Hermine H., Arnos, Kathleen S., Pandya, Arti

    Published in Journal of genetic counseling (01-12-2009)
    “…Hearing loss is a common sensory deficit and more than 50% of affected individuals have a genetic etiology. The discovery of 40 genes and more than 100 loci…”
    Get full text
    Journal Article
  14. 14

    Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD by Kempsford, Rodger, Norris, Virginia, Siederer, Sarah

    Published in Pulmonary pharmacology & therapeutics (01-04-2013)
    “…Abstract Vilanterol (VI; GW642444M) is a novel inhaled long-acting β2-agonist with inherent 24 h activity in vitro in development as a combination with the…”
    Get full text
    Journal Article
  15. 15

    Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD by Norris, Virginia, Ambery, Claire

    Published in Pulmonary pharmacology & therapeutics (01-10-2013)
    “…Abstract Background There are few data on the bronchodilatory effects of adding short-acting bronchodilators (SABA) to maintenance, long-acting bronchodilator…”
    Get full text
    Journal Article
  16. 16

    Use of Propranolol Blockade to Explore the Pharmacology of GSK961081, a Bi-Functional Bronchodilator, in Healthy Volunteers: Results from Two Randomized Trials by Norris, Virginia, Ambery, Claire

    Published in Drugs in R&D (01-12-2014)
    “…Purpose The objective of this study was to explore the pharmacology of GSK961081, a bi-functional bronchodilator, in healthy volunteers. Methods Two…”
    Get full text
    Journal Article
  17. 17

    "Drive-by English": Teaching College English to High School Students via Interactive TV by Blackstock, Alan, Exton, Virginia Norris

    Published in Teaching English in the two-year college (01-05-2005)
    “…This paper outlines challenges in and essential criteria for the success of dual-credit or concurrent-enrollment writing and literature courses delivered via…”
    Get more information
    Journal Article
  18. 18

    Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study by Reilmann, Ralf, Grachev, Igor D, Savola, Juha-Matti, Borowsky, Beth, Eyal, Eli, Gross, Nicholas, Langbehn, Douglas, Schubert, Robin, Wickenberg, Anna Teige, Papapetropoulos, Spyros, Squitieri, Ferdinando, Kieburtz, Karl, Landwehrmeyer, G Bernhard, Agarwal, Pinky, Anderson, Karen E, Aziz, Nasir A, Azulay, Jean-Phillippe, Bachoud-Levi, Anne C, Barker, Roger, Bebak, Agnieszka, Beuth, Markus, Biglan, Kevin, Blin, Stephanie, Bonelli, Raphael, Caldwell, Sue, Calvas, Fabienne, Carlos, Jonielyn, Chong, Terrence, Chua, Phyllis, Coleman, Allison, Corey-Bloom, Jody, Cousins, Rebecca, Craufurd, David, De Michele, Giuseppe, Dornhege, Laura, Feigin, Andrew, Gallehawk, Stephanie, Gauteul, Pascale, Gonzales, Carey, Griffith, Jane, Guttman, Mark, Heim, Beatrix, Heller, Hope, Hjermind, Lena, Ivanko, Larry, Jaynes, Jessica, Jenckes, Mollie, Kaminski, Barbara, Kampstra, Anne, Konkel, Agnieszka, Kopishinskaya, Svetlana, Krystkowiak, Pierre, Komati, Suresh K, Lakoning, Stefan, Latipova, Guzal, Leavitt, Blair, Loy, Clement, Madsen, Louise, Marder, Karen, Mason, Sarah, Mendis, Neila, Mendis, Tilak, Norris, Virginia, Olivier, Audrey, Orth, Michael, Owens, Ashley, Panegyres, Peter, Perlman, Susan, Preston, Joy, Puch, Alicja, Rialland, Amandine, Rickards, Hugh, Romoli, Anna M, Ross, Christopher, Rosser, Anne, Rudzinska, Monika, Russo, Cinzina V, Saft, Carsten, Segro, Victoria, Seppi, Klaus, Shannon, Barbara, Shprecher, David, Simonin, Clemence, Skitt, Zara, Soliveri, Paola, Squitieri, Ferdinando, Suski, Valarie, Stepniak, Iwona, Sungmee, Park, Temirbaeva, Sofia, Uhl, Stefanie, Vangsted-Hansen, Christina, Verny, Christophe, Wall, Paola, Walker, Francis, Wasserman, Paula, Witkowski, Grzegorz, Wright, Jan, Zalyalova, Zuleykha, Zielonka, Daniel

    Published in Lancet neurology (01-02-2019)
    “…Previous trials have shown that pridopidine might reduce motor impairment in patients with Huntington's disease. The aim of this study was to ascertain whether…”
    Get full text
    Journal Article
  19. 19

    Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers by Norris, Virginia, Warrington, Steve, Boyce, Malcolm

    Published in Journal of interferon & cytokine research (01-02-2016)
    “…Interferon beta-1a (IFNβ-1a) 30 μg weekly by intramuscular (IM) injection is used to treat relapsing forms of multiple sclerosis. We assessed if it can be…”
    Get more information
    Journal Article
  20. 20

    Pharmacodynamics of GSK961081, a bi-functional molecule, in patients with COPD by Bateman, Eric D, Kornmann, Oliver, Ambery, Claire, Norris, Virginia

    Published in Pulmonary pharmacology & therapeutics (01-10-2013)
    “…Abstract GSK961081 is an inhaled bi-functional molecule with both muscarinic antagonism and β2 -agonism (MABA) properties. This randomised, double-blind,…”
    Get full text
    Journal Article